Real-world use of trifluridine/tipiracil for patients with metastatic colorectal cancer in Canada.
Conclusions: In advanced mcrc, ftd/tpi is a well-tolerated therapy. The large number of patients enrolled in the access programs within a short period of time is reflective of major clinical need in this area, with many patients being eligible and interested in pursuing treatment in the refractory setting.
PMID: 31708650 [PubMed - in process]
Source: Current Oncology - Category: Cancer & Oncology Tags: Curr Oncol Source Type: research
More News: Canada Health | Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Eloxatin | Pharmaceuticals | Study